$OPRA Cashflow Statement | Understand Stock

$OPRA

$18.36 +$0.67 (3.79%) Close

$OPRA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statement of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Loss before income taxes from discontinued operations
Income before income taxes
Adjustments to reconcile income before income taxes to net cash flow from operating activities:
Net finance (income) expense
Fair value gain on long-term investments
Share of net (income) loss of equity-accounted investees
Impairment of equity-accounted investee
Gain on disposal of emerging market fintech operations
Impact of divestment of joint venture
Impairment of non-financial assets
Depreciation and amortization
Cost of equity awards
Share-based compensation
Other adjustments

Changes in working capital:
Trade and other receivables
Change in inventories
Change in loans to customers
Other current assets
Trade and other payables
Deferred revenue
Other liabilities
Income taxes paid
Net cash flow from operating activities

Cash flows from investing activities:
Purchase of equipment
Purchase of intangible assets
Proceeds from sales of equipment and intangible assets
Development expenditure
Investment in an associate
Cash transferred upon loss of control over emerging market fintech operations
Deposit of collateral for subsidiaries' loan facility
Release of escrow account
Disbursement of short-term loans
Repayment of short-term loans
Investment in, and loans to associates and joint ventures
Repayment of loans to associates and joint ventures
Sale of long-term investments
Net sale of short-term investments
Interest received
Net cash flow from (used in) investing activities

Cash flows from financing activities:
Proceeds from issues of equity instruments
Transaction costs on issue of equity instruments
Share repurchases
Proceeds from loans and borrowings
Dividends paid
Proceeds from exercise of share options
Repayment of borrowings
Payment of lease liabilities
Interest paid
Net cash flow used in financing activities

Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Effect of exchange rate changes on cash and cash equivalents
Cash and cash equivalents at end of period

Comments